RADIATION · Unmapped registry intervention
3-Dimensional Conformal Radiation Therapy
Find medicine records ·
Find other trials using this name
Clinical trial
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
NCT04423211
Drugs and interventions used in this trial
18 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Apalutamide
Normalized identity: apalutamideView linked drug · Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
Computed Tomography
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Degarelix
Normalized identity: degarelixView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
External Beam Radiation Therapy
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Fluciclovine F18
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Goserelin Acetate
Normalized identity: goserelin acetateView linked drug · Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
Intensity-Modulated Proton Therapy
Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
Intensity-Modulated Radiation Therapy
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Leuprolide Acetate
Normalized identity: leuprolide acetateView linked drug · Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
Magnetic Resonance Imaging
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
Positron Emission Tomography
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Quality-of-Life Assessment
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Questionnaire Administration
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Relugolix
Normalized identity: relugolixView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
Stereotactic Body Radiation Therapy
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Triptorelin
Normalized identity: triptorelinView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
Volume Modulated Arc Therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
ApalutamideDRUG · verified · RxNorm: apalutamide
Computed TomographyPROCEDURE
DegarelixDRUG · verified · RxNorm: degarelix
External Beam Radiation TherapyRADIATION
Fluciclovine F18OTHER
Goserelin AcetateDRUG · verified · RxNorm: goserelin acetate
Intensity-Modulated Proton TherapyPROCEDURE
Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate
Magnetic Resonance ImagingPROCEDURE
Positron Emission TomographyPROCEDURE
RelugolixDRUG · verified · RxNorm: relugolix
Stereotactic Body Radiation TherapyRADIATION
TriptorelinDRUG · verified · RxNorm: triptorelin
Volume Modulated Arc TherapyRADIATION
Sponsors & collaborators
ECOG-ACRIN Cancer Research Grouplead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
New YorkNew York, United States7St LouisMissouri, United States6SeattleWashington, United States6PittsburghPennsylvania, United States6PhiladelphiaPennsylvania, United States5PortlandOregon, United States4ChicagoIllinois, United States3Los AngelesCalifornia, United States3DallasTexas, United States3CincinnatiOhio, United States3TampaFlorida, United States3MinneapolisMinnesota, United States3
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04423211 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.